Connect with us

International

FDA OKs First Blood Test For Alzheimer’s Detection

UNITED STATES – For the first time, the Food and Drug Administration (FDA) has approved a blood test to help detect Alzheimer’s disease.

Published

on

UNITED STATES – For the first time, the Food and Drug Administration (FDA) has approved a blood test to help detect Alzheimer’s disease.

The test, for patients 55 and older showing symptoms, measures protein levels in the blood linked to signs of the disease, offering a less invasive option than costly brain scans or spinal taps.

It’s not a stand-alone diagnostic tool but doctors say it’s a major step toward faster, easier diagnoses.

With Alzheimer’s cases expected to double by 2060, experts say early detection is more critical than ever.

Advertisement
Advertisement
Advertisement
Advertisement
Advertisement
Advertisement
Advertisement
Advertisement
Advertisement
Advertisement
Advertisement
Advertisement
Advertisement
Advertisement
Advertisement
Advertisement
Advertisement
Advertisement

Trending